News

Mark Esser, an executive at Big Pharma firm AstraZeneca, has been named the inaugural leader of UVa's future Manning ...
On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy over its use of non-human primates, plunged 28 percent after the FDA issued ...
No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception ... Every step of the way needs to be tested in the laboratory, in live cells, animal,s or humans. This ...
There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.
Cell programming biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of therapeutics development. The decision was driven by “shifting ...
With accessible diagnostics at the forefront of the biotech industry, Cue Health has been paving the way since 2010 to provide patients with the tools and resources to effectively manage their own ...
The Cambridge, Massachusetts-based biotech is closing “following careful consideration of potential paths forward and strategic factors,” HC CEO and cofounder Leslie Williams said in an ...
Credit: Rocket Lab webcast WASHINGTON — Rocket Lab has completed the deployment of a constellation of Internet-of-Things satellites for French company Kinéis with a launch March 17. An Electron ...
In the cutting-edge world of biotechnology, your lab's proprietary information is its lifeblood. As such, ensuring the security of your intellectual property, research data, and trade secrets is ...
A Boston biotech try­ing to bring trans­fer RNA (tR­NA) bi­ol­o­gy to the drug de­vel­op­ment field has shut­tered op­er­a­tions, End­points News has learned.